UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 14A
 Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934

Filed by the Registrant x
Filed by a Party other than the Registrant 
Check the appropriate box:
 Preliminary Proxy Statement
 Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
 Definitive Proxy Statement
x
 Definitive Additional Materials
 Soliciting Material under §240.14a-12
haelogo2a07.jpg
HAEMONETICS CORPORATION
(Name of Registrant as Specified in Its Charter)
Payment of Filing Fee (Check the appropriate box):
xNo fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.



notice1.jpg





notice2.jpg


Haemonetics (NYSE:HAE)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Haemonetics Charts.
Haemonetics (NYSE:HAE)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Haemonetics Charts.